|
141 |
Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents Enthalten in BMC gastroenterology Bd. 14, 3.10.2014, Nr. 1, date:12.2014: 1-9
|
|
|
142 |
Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience Enthalten in Journal of gastroenterology Bd. 51, 22.12.2015, Nr. 5, date:5.2016: 421-433
|
|
|
143 |
Safe recovery of a fully fractured basket in the bile duct using endoscopic papillary large balloon dilation Enthalten in Endoscopy Bd. 46, 2014, Nr. S 01, 01: E365-E366
|
|
|
144 |
Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma Enthalten in Hepatology international Bd. 5, 22.1.2011, Nr. 3, date:9.2011: 850-856
|
|
|
145 |
Sorafenib treatment in Child–Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors Enthalten in Investigational new drugs Bd. 33, 12.4.2015, Nr. 3, date:6.2015: 729-739
|
|
|
146 |
Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL) Enthalten in Medical oncology Bd. 36, 3.5.2019, Nr. 6, date:6.2019: 1-11
|
|
|
147 |
Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report Enthalten in BMC gastroenterology Bd. 16, 11.7.2016, Nr. 1, date:12.2016: 1-4
|
|
|
148 |
Suppressed neutrophil function in children with acute lymphoblastic leukemia Enthalten in International journal of hematology Bd. 90, 2.9.2009, Nr. 3, date:10.2009: 311-317
|
|
|
149 |
The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study Enthalten in Journal of gastroenterology Bd. 47, 25.10.2011, Nr. 3, date:3.2012: 313-320
|
|
|
150 |
The FLS (Fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis Enthalten in BMC gastroenterology Bd. 13, 23.7.2013, Nr. 1, date:12.2013: 1-11
|
|